Lv5
970 积分 2024-06-12 加入
Transformation of NSCLC to SCLC harboring EML4–ALK fusion with V1180L mutation after alectinib resistance and response to lorlatinib: A case report and literature review
2个月前
已完结
Overcoming resistance to anti-PD-1 immunotherapy in lymphoepithelioma-like carcinoma: A case report and review of the literature
2个月前
已完结
Identification of a EML4-ALK exon 19 fusion variant in lung adenocarcinoma and alectinib resistance
2个月前
已完结
Identification of I1171N resistance mutation in ALK-positive non-small-cell lung cancer tumor sample and circulating tumor DNA
2个月前
已完结
Transformation to neuroendocrine carcinoma as a resistance mechanism to lorlatinib
2个月前
已完结
First case report of transformation of adenocarcinoma to adenosquamous carcinoma with giant-cell carcinoma harboring HER2 mutation after zongertinib (BI 1810631) resistance
2个月前
已完结
Characteristics of Patients with Non-Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 20 Q787Q Mutation
3个月前
已完结
The crowns
10个月前
已关闭
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
10个月前
已完结
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
10个月前
已完结
皖公网安备34019202002308
